{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:59:32Z","timestamp":1792839572752,"version":"4.5.0"},"reference-count":213,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00398"],"award-info":[{"award-number":["PI17\/00398"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PIE15\/00027"],"award-info":[{"award-number":["PIE15\/00027"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008318","name":"Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF-2016-75767-R"],"award-info":[{"award-number":["SAF-2016-75767-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018381","name":"Stiftung f\u00fcr Leberkrankheiten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009253","name":"European Association for the Study of the Liver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-14-CE12-0011"],"award-info":[{"award-number":["ANR-14-CE12-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-14-CE35-0022"],"award-info":[{"award-number":["ANR-14-CE35-0022"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-CE14-0006-01"],"award-info":[{"award-number":["ANR-18-CE14-0006-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jhep.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:02:08Z","timestamp":1551182528000},"page":"175-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis"],"prefix":"10.1016","volume":"71","author":[{"given":"Virginia","family":"Hern\u00e1ndez-Gea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Rautou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garcia-Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.02.015_b0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.dld.2018.04.004","article-title":"The epidemiology of Budd-Chiari syndrome in France","volume":"50","author":"Ollivier-Hourmand","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2019.02.015_b0010","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/liv.13008","article-title":"Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study","volume":"36","author":"Ki","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/ATVBAHA.110.213371","article-title":"Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences","volume":"31","author":"Smalberg","year":"2011","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2019.02.015_b0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/gut.48.2.264","article-title":"Factor V Leiden related Budd-Chiari syndrome","volume":"48","author":"Deltenre","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.02.015_b0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.02.015_b0045","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1160\/TH12-10-0784","article-title":"Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature","volume":"109","author":"Qi","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0050","first-page":"59","article-title":"Spectrum of hemostatic derangements, in Budd-Chiari syndrome","volume":"22","author":"Pati","year":"2003","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0055","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/apt.13815","article-title":"Review article: the aetiology of primary Budd-Chiari syndrome \u2013 differences between the West and China","volume":"44","author":"Qi","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.02.015_b0060","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.112.094920","article-title":"Deletion of microvesicles from the circulation","volume":"125","author":"Rautou","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2019.02.015_b0065","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/s41598-017-04773-8","article-title":"Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2019.02.015_b0070","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2003-06-1789","article-title":"Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia","volume":"102","author":"Kerlin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jth.13911","article-title":"Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis","volume":"16","author":"Iba","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0080","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1160\/TH16-03-0246","article-title":"Inflammation and thrombosis \u2013 testing the hypothesis with anti- inflammatory drug trials","volume":"116","author":"De Caterina","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL Clinical Practice Guidelines: vascular diseases of the liver","volume":"64","author":"Association","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0095","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood-2008-06-164087","article-title":"Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera","volume":"112","author":"Marchetti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0100","first-page":"1712","article-title":"Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome","volume":"91","author":"Smalberg","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jhep.2019.02.015_b0105","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1182\/blood-2007-11-125328","article-title":"The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases","volume":"111","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0110","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2040620716680333","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease","volume":"8","author":"How","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1309\/AJCP7VO4HAIZYATP","article-title":"JAK2 mutations across a spectrum of venous thrombosis cases: table 1","volume":"134","author":"Shetty","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jhep.2019.02.015_b0125","first-page":"279","article-title":"Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis","volume":"32","author":"Deepak","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0130","first-page":"130","article-title":"Hepatic vein obstruction is the most common type of hepatic venous outflow obstruction regardless of socioeconomic status","volume":"27","author":"Shukla","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-017-9810-5","article-title":"Budd-Chiari syndrome\/hepatic venous outflow tract obstruction","volume":"12","author":"Valla","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jgh.12379","article-title":"JAK2 V617F mutation and 46\/1 haplotype in Chinese Budd-Chiari syndrome patients","volume":"29","author":"Wang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0145","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0150","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.02.015_b0155","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.02.015_b0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2014.08.032","article-title":"Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis","volume":"62","author":"Turon","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0165","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2014.120857","article-title":"Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis","volume":"100","author":"Plompen","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jhep.2019.02.015_b0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2017.04.021","article-title":"Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: a prospective cohort study","volume":"67","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0175","first-page":"369","article-title":"Outcome of diabetic pregnancies in Waikato: five year experience","volume":"98","author":"Karalus","year":"1985","journal-title":"New Zel Med J"},{"key":"10.1016\/j.jhep.2019.02.015_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11899-018-0446-x","article-title":"Splanchnic vein thrombosis in the myeloproliferative neoplasms","volume":"13","author":"Akpan","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jhep.2019.02.015_b0185","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00277-014-2249-z","article-title":"Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis","volume":"94","author":"Iurlo","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjh.13121","article-title":"Incidence of CALR mutations in patients with splanchnic vein thrombosis","volume":"168","author":"Langabeer","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0195","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2008-11-191544","article-title":"The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome","volume":"113","author":"Sozer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0200","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2012-01-404889","article-title":"Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation","volume":"121","author":"Rosti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0205","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2010-07-297598","article-title":"Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms","volume":"117","author":"Teofili","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0210","first-page":"95321","article-title":"Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression","volume":"103","author":"Guy","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jhep.2019.02.015_b0215","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0220","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0225","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2018.01.010","article-title":"Endothelial JAK2V617Fdoes not enhance liver lesions in mice with Budd-Chiari syndrome","volume":"68","author":"Poisson","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0230","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2141.2012.09073.x","article-title":"Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab","volume":"157","author":"van Bijnen","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0235","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0240","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2009.06.019","article-title":"Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study","volume":"51","author":"Hoekstra","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0245","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-148-8-200804150-00003","article-title":"Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia","volume":"148","author":"Brodsky","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.02.015_b0250","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jhep.2015.07.026","article-title":"Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population","volume":"63","author":"Plompen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0255","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000496","article-title":"Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis","volume":"94","author":"Qi","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2019.02.015_b0260","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0265","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.semarthrit.2014.10.014","article-title":"An outcome survey of 43 patients with Budd-Chiari syndrome due to Beh\u00e7et\u2019s syndrome followed up at a single, dedicated center","volume":"44","author":"Seyahi","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jhep.2019.02.015_b0270","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/blood-2016-05-716720","article-title":"Thrombosis in the setting of obesity or inflammatory bowel disease","volume":"128","author":"Lentz","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0275","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2015.08.024","article-title":"Central obesity is associated with non-cirrhotic portal vein thrombosis","volume":"64","author":"Bureau","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0280","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2019.02.015_b0285","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.metabol.2011.03.019","article-title":"Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects","volume":"60","author":"Magkos","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2019.02.015_b0290","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009336","article-title":"Venous thromboembolism related to cytomegalovirus infection: a case report and literature review","volume":"96","author":"Kelkar","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2019.02.015_b0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/sarh.2002.28303","article-title":"Viral infections and antiphospholipid antibodies","volume":"31","author":"Uthman","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jhep.2019.02.015_b0300","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.10130","article-title":"Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo","volume":"46","author":"Gharavi","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2019.02.015_b0305","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/blood.V84.11.3749.bloodjournal84113749","article-title":"Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid","volume":"84","author":"Pryzdial","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0310","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0168-8278(99)80294-3","article-title":"Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts","volume":"31","author":"Evans","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1160\/TH04-08-0523","article-title":"Effects of human cytomegalovirus infection on the coagulation system","volume":"93","author":"Squizzato","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0320","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0325","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.12111785","article-title":"Obliterative portal venopathy: findings at CT imaging","volume":"263","author":"Glatard","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2019.02.015_b0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199401000-00003","article-title":"Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature","volume":"73","author":"Dilawari","year":"1994","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2019.02.015_b0335","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in Budd-Chiari syndrome","volume":"39","author":"Langlet","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0340","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0016-5085(94)90765-X","article-title":"The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases","volume":"106","author":"Hadengue","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005792-198207000-00001","article-title":"Budd-Chiari syndrome: etiology, diagnosis and management","volume":"61","author":"Mitchell","year":"1982","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2019.02.015_b0350","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2002-23203","article-title":"Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy)","volume":"22","author":"Okuda","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2019.02.015_b0360","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002709900206","article-title":"Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study","volume":"21","author":"Sonomura","year":"1998","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0365","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ejrad.2009.01.012","article-title":"Regenerative nodules in patients with chronic Budd-Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT","volume":"73","author":"Flor","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0370","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510270224","article-title":"Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules","volume":"27","author":"Tanaka","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0375","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1089-3261(02)00016-8","article-title":"Benign liver tumors","volume":"6","author":"Wanless","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2019.02.015_b0380","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1148\/radiology.210.2.r99fe13443","article-title":"Hepatic nodules in Budd-Chiari syndrome: imaging features","volume":"210","author":"Vilgrain","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2019.02.015_b0385","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3350\/cmh.2015.21.1.89","article-title":"Budd-Chiari syndrome with multiple large regenerative nodules","volume":"21","author":"Kim","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0390","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s00261-018-1502-7","article-title":"Benign and malignant hepatocellular lesions in patients with vascular liver diseases","volume":"43","author":"Vilgrain","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0395","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2214\/ajr.178.4.1780869","article-title":"Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar","volume":"178","author":"Maetani","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2019.02.015_b0400","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jhep.2015.06.017","article-title":"Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders","volume":"63","author":"Sempoux","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0405","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.02.015_b0410","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MEG.0b013e32835eb8d4","article-title":"Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review","volume":"25","author":"Ren","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0415","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.13173","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction","volume":"41","author":"Paul","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.02.015_b0420","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/jhep.2003.50076","article-title":"Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers","volume":"37","author":"Cazals-Hatem","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0425","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2214\/ajr.178.4.1780877","article-title":"Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation","volume":"178","author":"Brancatelli","year":"2002","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jhep.2019.02.015_b0430","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2019.01.009","article-title":"Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome","volume":"70","author":"van Wettere","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0435","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.08.033","article-title":"Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis","volume":"151","author":"Sarin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b0440","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2214\/AJR.18.19548","article-title":"Portal vein thrombosis: Imaging the spectrum of disease with an emphasis on MRI features","volume":"211","author":"Jha","year":"2018","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jhep.2019.02.015_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162215","article-title":"Building a 3D virtual liver: methods for simulating blood flow and hepatic clearance on 3D structures","volume":"11","author":"White","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.02.015_b0450","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/liv.12386","article-title":"Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis","volume":"34","author":"Elkrief","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0455","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajg.2017.38","article-title":"Predictive factors of intestinal necrosis in acute mesenteric ischemia: prospective study from an intestinal stroke center","volume":"112","author":"Nuzzo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0460","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.28466","article-title":"Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis","volume":"63","author":"Noronha Ferreira","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0465","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1478-3231.2003.00879.x","article-title":"Hepatic dysfunction in patients with extrahepatic portal venous obstruction","volume":"23","author":"Rangari","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0470","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.21126","article-title":"Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy","volume":"43","author":"M\u00ednguez","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0475","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1572-0241.2008.01830.x","article-title":"Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0480","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/s00330-011-2161-z","article-title":"Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history","volume":"21","author":"Marin","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0485","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1022549018807","article-title":"Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients","volume":"48","author":"Kaymakoglu","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.02.015_b0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/thx.34.2.281","article-title":"Pulmonary hypertension complicating portal vein thrombosis","volume":"34","author":"Saunders","year":"1979","journal-title":"Thorax"},{"key":"10.1016\/j.jhep.2019.02.015_b0495","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jceh.2014.02.003","article-title":"cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver","volume":"4","author":"Dhiman","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0500","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/jhep.2003.50232","article-title":"Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study","volume":"37","author":"Asselah","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0505","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/gut.2010.230201","article-title":"Portal cholangiopathy: radiological classification and natural history","volume":"60","author":"Llop","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.02.015_b0510","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2214\/ajr.181.6.1811641","article-title":"Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome","volume":"181","author":"Bargall\u00f3","year":"2003","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jhep.2019.02.015_b0515","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00201775","article-title":"Budd-Chiari syndrome: imaging with pathologic correlation","volume":"18","author":"Miller","year":"1993","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jhep.2019.02.015_b0520","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.510300125","article-title":"Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting","volume":"30","author":"Zeitoun","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0525","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","article-title":"TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients","volume":"135","author":"Garcia-Pagan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b0530","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome","volume":"39","author":"Darwish Murad","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0535","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome","volume":"44","author":"Plessier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0540","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0168-8278(01)00131-3","article-title":"The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome","volume":"35","author":"Tang","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0545","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/lt.21171","article-title":"Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?","volume":"13","author":"Darwish","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.02.015_b0550","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ajg.2009.63","article-title":"Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management","volume":"104","author":"Rautou","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0555","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lt.24643","article-title":"Acute Liver Failure Study Group. Budd-chiari syndrome causing acute liver failure: a multicenter case series","volume":"23","author":"Parekh","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.02.015_b0560","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.cgh.2009.06.011","article-title":"Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome","volume":"7","author":"Rautou","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0565","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.02.015_b0570","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"De Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0575","first-page":"857A","article-title":"Impact of cytoreductive therapy on the outcome of patients with myeloproliferative neoplasms and hepatosplanchnic vein thrombosis","volume":"58","author":"Chagneau-Derrode","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0580","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13023-014-0153-1","article-title":"Behcet\u2019s disease in Budd-Chiari syndrome","volume":"9","author":"Desbois","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2019.02.015_b0585","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11605-011-1738-9","article-title":"Budd-Chiari syndrome revisited: 38 years\u2019 experience with surgical portal decompression","volume":"16","author":"Orloff","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2019.02.015_b0590","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2036.2009.04134.x","article-title":"Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival","volume":"30","author":"Montano-Loza","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.02.015_b0595","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2006.08.016","article-title":"Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome","volume":"46","author":"Bachet","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0605","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1253\/circj.CJ-17-0333","article-title":"Successful vascular intervention without embolic complications in Budd-Chiari syndrome","volume":"82","author":"Taguchi","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jhep.2019.02.015_b0610","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2003.09.028","article-title":"Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature","volume":"40","author":"Sharma","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0615","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","article-title":"Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis","volume":"100","author":"Smalberg","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0620","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/hep.510250405","article-title":"Hepatic venous outflow block caused by short-length hepatic vein stenoses","volume":"25","author":"Valla","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0625","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1148\/radiol.12120856","article-title":"Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center","volume":"266","author":"Han","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2019.02.015_b0630","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14295","article-title":"Comparison of retrievable stents and permanent stents for Budd-Chiari syndrome due to obstructive inferior vena cava","author":"Bi","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0635","first-page":"453","article-title":"Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome","volume":"174","author":"Shaked","year":"1992","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jhep.2019.02.015_b0640","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/jlts.2003.50156","article-title":"Surgical treatment of Budd-Chiari syndrome","volume":"9","author":"Klein","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.02.015_b0645","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jss.2009.07.024","article-title":"Long-term follow-up study and comparison of meso-atrial shunts and meso-cavo-atrial shunts for treatment of combined Budd-Chiari syndrome","volume":"168","author":"Chen","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.jhep.2019.02.015_b0650","first-page":"155","article-title":"Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome?","volume":"65","author":"Langlet","year":"2002","journal-title":"Acta Gastroenterol Belga"},{"key":"10.1016\/j.jhep.2019.02.015_b0655","first-page":"276","article-title":"Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries","volume":"115","author":"Panis","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2019.02.015_b0660","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00000658-200009000-00006","article-title":"A 27-year experience with surgical treatment of Budd-Chiari syndrome","volume":"232","author":"Orloff","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2019.02.015_b0665","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9610(99)80095-6","article-title":"Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation","volume":"171","author":"Hemming","year":"1996","journal-title":"Am J Surg"},{"key":"10.1016\/j.jhep.2019.02.015_b0670","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiol.2016152641","article-title":"Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome","volume":"283","author":"Hayek","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2019.02.015_b0675","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MEG.0000000000000653","article-title":"In favour of early intervention for Budd-Chiari syndrome","volume":"28","author":"Mancuso","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0680","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/MEG.0000000000000945","article-title":"Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome","volume":"29","author":"Shalimar","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0685","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jgh.13456","article-title":"Endovascular treatment of Budd-Chiari syndrome: single center experience","volume":"32","author":"Rathod","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0690","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1007\/s10620-016-4208-0","article-title":"Good clinical outcomes in Budd-Chiari syndrome with hepatic vein occlusion","volume":"61","author":"Fan","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.02.015_b0695","doi-asserted-by":"crossref","first-page":"36380","DOI":"10.1038\/srep36380","article-title":"Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins","volume":"6","author":"He","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2019.02.015_b0700","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/liv.12355","article-title":"Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre","volume":"34","author":"Qi","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0705","article-title":"Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: a pilot study","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.02.015_b0710","first-page":"641","article-title":"Orthotopic liver transplant for Budd-Chiari syndrome: an analysis of 14 cases","volume":"14","author":"Do\u011frul","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jhep.2019.02.015_b0715","first-page":"1285","article-title":"Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis","volume":"13","author":"Segev","year":"2007","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2019.02.015_b0720","first-page":"144","article-title":"Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome","volume":"14","author":"Ulrich","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.02.015_b0725","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","article-title":"Liver transplantation for Budd \u2013 Chiari syndrome: a European study on 248 patients from 51 centres","volume":"44","author":"Mentha","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0730","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00007890-200203270-00026","article-title":"Liver transplantation for Budd-Chiari syndrome","volume":"73","author":"Srinivasan","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.02.015_b0735","first-page":"177","article-title":"Experience of liver transplant in patients diagnosed with Budd-Chiari syndrome","volume":"16","author":"Raza","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jhep.2019.02.015_b0740","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/liv.12816","article-title":"Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms","volume":"35","author":"Potthoff","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0745","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00007890-200210270-00006","article-title":"Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders","volume":"74","author":"Melear","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.02.015_b0750","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/TP.0b013e3182247b05","article-title":"Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology","volume":"92","author":"Chinnakotla","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.02.015_b0755","first-page":"501","article-title":"High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome","volume":"19","author":"Cruz","year":"2005","journal-title":"ClinTransplant"},{"key":"10.1016\/j.jhep.2019.02.015_b0760","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/lt.21714","article-title":"Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab","volume":"15","author":"Singer","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.02.015_b0765","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1432-2277.2003.tb00260.x","article-title":"Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria","volume":"16","author":"Bahr","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0770","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.transproceed.2017.04.028","article-title":"Living-donor liver transplantation for Budd-Chiari syndrome: case series","volume":"49","author":"Karaca","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2019.02.015_b0775","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005136","article-title":"Living donor liver transplantation for Budd-Chiari syndrome: overcoming a troublesome situation","volume":"95","author":"Ara","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2019.02.015_b0780","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0785","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2000.16597","article-title":"Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy","volume":"32","author":"Condat","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0790","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.6319","article-title":"Epidemiology, risk and prognostic factors in mesenteric venous thrombosis","volume":"95","author":"Acosta","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2019.02.015_b0795","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2008.07.031","article-title":"Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation","volume":"6","author":"Turnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0800","doi-asserted-by":"crossref","first-page":"141","DOI":"10.14740\/gr806w","article-title":"Efficacy and safety of direct-acting oral anticoagulants use in acute portal vein thrombosis unrelated to cirrhosis","volume":"10","author":"Nery","year":"2017","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.jhep.2019.02.015_b0805","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8432781","article-title":"Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis","volume":"2018","author":"Priyanka","year":"2018","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0810","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mayocp.2017.10.007","article-title":"Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location","volume":"93","author":"Janczak","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2019.02.015_b0815","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.seminhematol.2018.04.001","article-title":"Ten years of clinical experience with eculizumab in patients with paroxysmal nocturnal hemoglobinuria","volume":"55","author":"Sicre de Fontbrune","year":"2018","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0820","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0825","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.avsg.2016.06.029","article-title":"Comparison of systemic thrombolysis versus indirect thrombolysis via the superior mesenteric artery in patients with acute portal vein thrombosis","volume":"39","author":"Liu","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jhep.2019.02.015_b0830","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jceh.2014.03.052","article-title":"Mesenteric venous thrombosis","volume":"4","author":"Hmoud","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0835","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b0840","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2006.09.030","article-title":"Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up","volume":"5","author":"Orr","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0845","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b0850","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MEG.0000000000001061","article-title":"Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation","volume":"30","author":"Guillaume","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0855","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/liv.13728","article-title":"Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients","volume":"38","author":"Bianchini","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0860","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2036.2007.03488.x","article-title":"Review article: The management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults","volume":"26","author":"Spaander","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.02.015_b0865","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0870","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0032-1326227","article-title":"Self-expandable metal stents as definitive treatment for esophageal variceal bleeding","volume":"45","author":"Holster","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2019.02.015_b0875","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","article-title":"Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding","volume":"11","author":"Spaander","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0880","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000280466","article-title":"Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis","volume":"123","author":"Randi","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0885","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0043-121348","article-title":"Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis","volume":"56","author":"Klinger","year":"2018","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0890","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.dld.2009.08.003","article-title":"Portal vein thrombosis, revisited","volume":"42","author":"Primignani","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2019.02.015_b0895","first-page":"893","article-title":"Expert pediatric opinion on the report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"10","author":"Shneider","year":"2006","journal-title":"PediatrTransplant"},{"key":"10.1016\/j.jhep.2019.02.015_b0900","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12072-018-9844-3","article-title":"Idiopathic portal hypertension and extrahepatic portal venous obstruction","volume":"12","author":"Khanna","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2019.02.015_b0905","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/hep.28153","article-title":"Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium","volume":"63","author":"Shneider","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0910","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","article-title":"Pretransplant portal vein recanalization\u2014transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis","volume":"99","author":"Salem","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.02.015_b0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort","volume":"28","author":"Thornburg","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0920","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.tvir.2016.01.006","article-title":"Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations","volume":"19","author":"Thornburg","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b0925","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.28429","article-title":"Noncirrhotic complete obliterative portal vein thrombosis: novel management using trans-splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization","volume":"63","author":"Kallini","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b0930","article-title":"Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion","author":"Marot","year":"2018","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jhep.2019.02.015_b0935","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0168-8278(96)80328-X","article-title":"Biliary obstruction caused by portal cavernoma: a study of 8 cases","volume":"25","author":"Perlemuter","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b0940","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.3748\/wjg.v22.i45.9909","article-title":"Therapeutic approaches for portal biliopathy: a systematic review","volume":"22","author":"Franceschet","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.02.015_b0945","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0950","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.103","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients","volume":"6","author":"De Stefano","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jhep.2019.02.015_b0955","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1538-7836.2011.04484.x","article-title":"Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms","volume":"9","author":"Hoekstra","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0960","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/ajh.24993","article-title":"Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: the Mayo clinic experience with 84 consecutive cases","volume":"93","author":"Lavu","year":"2018","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.jhep.2019.02.015_b0965","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm","volume":"2018","author":"Finazzi","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jhep.2019.02.015_b0970","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.02.015_b0975","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1182\/blood-2013-01-478891","article-title":"Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project","volume":"121","author":"Barosi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.02.015_b0980","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.24607","article-title":"Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Tefferi","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2019.02.015_b0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2011.04562.x","article-title":"Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"10","author":"Van Bijnen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b0990","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/ATVBAHA.115.303397","article-title":"Overview of the new oral anticoagulants: opportunities and challenges","volume":"35","author":"Yeh","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2019.02.015_b0995","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b1000","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.12.018","article-title":"Gastrointestinal safety of direct oral anticoagulants: a large population-based study","volume":"152","author":"Abraham","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.02.015_b1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.04.031","article-title":"Risk of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis","volume":"15","author":"Miller","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b1010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.27225","article-title":"Treating thrombosis in cirrhosis patients with new oral agents: ready or not?","volume":"61","author":"Intagliata","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b1015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.26998","article-title":"Treatment of acute portal vein thrombosis by nontraditional anticoagulation","volume":"60","author":"Martinez","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b1020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH13-05-0407","article-title":"Successful treatment of acute portal vein thrombosis with rivaroxaban","volume":"110","author":"Pannach","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2019.02.015_b1025","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27541","article-title":"Use of nontraditional anticoagulants in portal vein thrombosis: a note of caution","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.02.015_b1030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.02.015_b1035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2009.02.028","article-title":"Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes","volume":"51","author":"Rautou","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b1040","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2012.07.034","article-title":"Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome","volume":"57","author":"Hoekstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b1045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jceh.2014.12.007","article-title":"Pregnancy and vascular liver disease","volume":"5","author":"Bissonnette","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b1050","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jhep.2018.08.007","article-title":"Pregnancy in idiopathic non-cirrhotic portal hypertension: a multicentric study on maternal and fetal management and outcome","volume":"69","author":"Andrade","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.02.015_b1055","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","article-title":"Thrombosis in pregnancy: maternal and fetal issues","volume":"353","author":"Greer","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jhep.2019.02.015_b1060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.gcb.2008.02.028","article-title":"Grossesse et hypertension portale","volume":"32","author":"d\u2019Alteroche","year":"2008","journal-title":"Gastroent\u00e9rologie Clin Biol"},{"key":"10.1016\/j.jhep.2019.02.015_b1065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/0284185113475917","article-title":"Treatment of postoperative main portal vein and superior mesenteric vein thrombosis with balloon angioplasty and\/or stent placement","volume":"54","author":"Cao","year":"2013","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jhep.2019.02.015_b1070","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0284185115595060","article-title":"Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver","volume":"57","author":"Rosenqvist","year":"2016","journal-title":"Acta Radiol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819301308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819301308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:36:26Z","timestamp":1759174586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819301308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":213,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0168827819301308"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.02.015","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}